Comparative Effects of Alexander Techniques and Feldenkrais Method in Parkinson's Disease (NCT06750224) | Clinical Trial Compass
By InvitationNot Applicable
Comparative Effects of Alexander Techniques and Feldenkrais Method in Parkinson's Disease
Pakistan46 participantsStarted 2024-10-01
Plain-language summary
Parkinson's disease (PD) is a neurodegenerative disorder characterized by tremors, rigidity, and postural instability. These symptoms significantly impact balance and increase the risk of falls, which subsequently lead to a heightened fear of falling and a diminished quality of life. Alexander Technique and the Feldenkrais Method have shown effects in improving overall well-being.
The study is randomized clinical trial will be carried at General hospital. 46 participants meeting the inclusion criteria will be included in this study. Participants will be randomly assigned into 2 groups, Group A and Group B participants will receive Alexander techniques and Feldenkrais method, respectively. All the groups will receive interventions for three days a week for 8 weeks.
Who can participate
Age range
50 Years – 70 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* The age group of 50 to 70 years will be included.
* Both genders (male and female)
* Patients diagnosed with Parkinson's disease of Hoehn and Yahr stage (1-3).
* Patient should be able to stand 10 minutes at least without assistance.
* Patients should be able to walk with or without assistance.
* MMSE (score higher than 24).
Exclusion Criteria:
* Recent surgery or any fracture
* Visual and hearing impairments.
* CVS impairments that interfered with therapy
* Joint pain or musculoskeletal problem that interfered with therapy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Berg balance scale
Timeframe: 8 weeks
2
Time up and go (TUG)
Timeframe: 8 weeks
3
Fall efficacy scale-international (FES-I)
Timeframe: 8 weeks
4
Quality of life questionnaire for Parkinson's PDQ-39